Treatment of conditions relating to hormone deficiencies by administration of progestins

Details for Australian Patent Application No. 2002309919 (hide)

International Classifications

Event Publications

19 December 2002 Complete Application Filed

Priority application(s): 60/291,488 16.05.01 US

1 May 2003 Application Open to Public Inspection

Published as AU-B-2002309919

24 June 2004 Amendment Made

The nature of the amendment is: Amend the name of the applicant from Endeavor Pharmaceuticals to Endeavor Pharmaceuticals, Inc.

24 June 2004 Assignment before Grant

Endeavor Pharmaceuticals, Inc. The application has been assigned to Barr Laboratories, Inc.

10 April 2008 Application Accepted

Published as AU-B-2002309919

7 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.